AIMS: Our objective was to examine prospectively the associations between fasting plasma proinsulin and the proinsulin/insulin ratio and the incidence of Type 2 diabetes in women. SUBJECTS AND METHODS: We designed a nested case-control study within the Nurses' Health Study, a cohort of 121,700 US women aged 30-55 years at study inception in 1976. Fasting plasma proinsulin, specific insulin and C-peptide levels were determined in 183 women with a new diagnosis of diabetes made after blood sampling between 1989 and 1990, and 369 control subjects without diabetes. RESULTS: After adjustment for age, body mass index, family history of diabetes and other potential confounders, including HbA1c, the odds ratios for diabetes associated with increasing quartiles of proinsulin were 1.00, 0.85, 2.49 and 5.73 (P for trend: < 0.001). Proinsulin remained significantly associated with diabetes risk after adjusting for C-peptide and specific insulin (multivariate odds ratios for quartiles: 1.00, 0.78, 1.94, 3.69; P for trend = 0.001). In addition, the proinsulin/insulin ratio was significantly associated with diabetes risk, controlling in multivariate analysis for C-peptide (odds ratios for extreme quartiles: 2.48; 95% CI: 1.14-5.41; P for trend = 0.005). CONCLUSIONS: These data suggest that proinsulin and the proinsulin/insulin ratio are strong independent predictors of diabetes risk, after adjustment for obesity and other potential confounders.
AIMS: Our objective was to examine prospectively the associations between fasting plasma proinsulin and the proinsulin/insulin ratio and the incidence of Type 2 diabetes in women. SUBJECTS AND METHODS: We designed a nested case-control study within the Nurses' Health Study, a cohort of 121,700 US women aged 30-55 years at study inception in 1976. Fasting plasma proinsulin, specific insulin and C-peptide levels were determined in 183 women with a new diagnosis of diabetes made after blood sampling between 1989 and 1990, and 369 control subjects without diabetes. RESULTS: After adjustment for age, body mass index, family history of diabetes and other potential confounders, including HbA1c, the odds ratios for diabetes associated with increasing quartiles of proinsulin were 1.00, 0.85, 2.49 and 5.73 (P for trend: < 0.001). Proinsulin remained significantly associated with diabetes risk after adjusting for C-peptide and specific insulin (multivariate odds ratios for quartiles: 1.00, 0.78, 1.94, 3.69; P for trend = 0.001). In addition, the proinsulin/insulin ratio was significantly associated with diabetes risk, controlling in multivariate analysis for C-peptide (odds ratios for extreme quartiles: 2.48; 95% CI: 1.14-5.41; P for trend = 0.005). CONCLUSIONS: These data suggest that proinsulin and the proinsulin/insulin ratio are strong independent predictors of diabetes risk, after adjustment for obesity and other potential confounders.
Authors: Matthias B Schulze; Kurt Hoffmann; JoAnn E Manson; Walter C Willett; James B Meigs; Cornelia Weikert; Christin Heidemann; Graham A Colditz; Frank B Hu Journal: Am J Clin Nutr Date: 2005-09 Impact factor: 7.045
Authors: Hans-Erik Johansson; Arvo Haenni; F Anders Karlsson; Britt Edén-Engström; Margareta Ohrvall; Magnus Sundbom; Björn Zethelius Journal: Obes Surg Date: 2010-05 Impact factor: 4.129
Authors: Christin Heidemann; Qi Sun; Rob M van Dam; James B Meigs; Cuilin Zhang; Shelley S Tworoger; Christos S Mantzoros; Frank B Hu Journal: Ann Intern Med Date: 2008-09-02 Impact factor: 25.391
Authors: Brian M Wolpin; Ying Bao; Zhi Rong Qian; Chen Wu; Peter Kraft; Shuji Ogino; Meir J Stampfer; Kaori Sato; Jing Ma; Julie E Buring; Howard D Sesso; I-Min Lee; John Michael Gaziano; Anne McTiernan; Lawrence S Phillips; Barbara B Cochrane; Michael N Pollak; JoAnn E Manson; Edward L Giovannucci; Charles S Fuchs Journal: J Natl Cancer Inst Date: 2013-07-11 Impact factor: 13.506
Authors: Jun Li; Megan S Rice; Tianyi Huang; Susan E Hankinson; Charles V Clevenger; Frank B Hu; Shelley S Tworoger Journal: Diabetologia Date: 2018-10-11 Impact factor: 10.122
Authors: Qi Sun; Rob M van Dam; James B Meigs; Oscar H Franco; Christos S Mantzoros; Frank B Hu Journal: Diabetes Date: 2009-12-03 Impact factor: 9.461
Authors: H-E Johansson; M Ohrvall; A Haenni; M Sundbom; B Edén Engström; F A Karlsson; B Zethelius Journal: Diabet Med Date: 2007-09-26 Impact factor: 4.359